Skip to content
PubMed This is a summary of 92 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 92 referenced papers

Top Authors

Sanjay V. Patel
Mayo Clinic
Ula V. Jurkunas
Massachusetts Eye and Ear Infirmary
Keith H. Baratz
Mayo Clinic
Gregory Moloney
The University of Sydney
Katrin Wacker
University of Freiburg
Lamis Baydoun
Netherlands Institute for Innovative Ocular Surgery
Stephan Ong Tone
Sunnybrook Health Science Centre
Naoki Okumura
Doshisha University
Gerrit R.J. Melles
Netherlands Institute for Innovative Ocular Surgery
Silke Oellerich
Netherlands Institute for Innovative Ocular Surgery

Top Institutions

Ranked by publications Top 10 institutions
05

Netherlands Institute for Innovative Ocular Surgery

Rotterdam, The Netherlands

39 papers
08

Sunnybrook Health Science Centre

Toronto, Canada

11 papers

References

References (92)
  1. 1

    RNA toxicity and missplicing in the common eye disease fuchs endothelial corneal dystrophy.

    Du J, Aleff RA, Soragni E, et al.

    The Journal of biological chemistry 2015; (290(10)):5979-90 doi:10.1074/jbc.M114.621607.

    PMID: 25593321
  2. 2

    Trinucleotide Repeat Expansion in the TCF4 Gene in Fuchs' Endothelial Corneal Dystrophy in Japanese.

    Nakano M, Okumura N, Nakagawa H, et al.

    Investigative ophthalmology & visual science 2015; (56(8)):4865-9 doi:10.1167/iovs.15-17082.

    PMID: 26218914
  3. 3

    Glaucoma risks in advanced corneal surgery.

    Maurino V, Aiello F

    Progress in brain research 2015; (221()):271-95.

    PMID: 26518083
  4. 4

    Established and emerging ancillary techniques in management of microbial keratitis: a review.

    Robaei D, Carnt N, Watson S

    The British journal of ophthalmology 2016; (100(9)):1163-70 doi:10.1136/bjophthalmol-2015-307371.

    PMID: 26888977
  5. 5

    Fuchs endothelial corneal dystrophy: current perspectives.

    Vedana G, Villarreal G, Jun AS

    Clinical ophthalmology (Auckland, N.Z.) 2016; (10()):321-30 doi:10.2147/OPTH.S83467.

    PMID: 26937169
  6. 6

    Corneal Hydration Control in Fuchs' Endothelial Corneal Dystrophy.

    Wacker K, McLaren JW, Kane KM, et al.

    Investigative ophthalmology & visual science 2016; (57(11)):5060-5065 doi:10.1167/iovs.16-20205.

    PMID: 27661858
  7. 7

    Rate of Rejection After Descemet Stripping Automated Endothelial Keratoplasty in Fuchs Dystrophy: Three-Year Follow-up.

    Sepsakos L, Shah K, Lindquist TP, et al.

    Cornea 2016; (35(12)):1537-1541 doi:10.1097/ICO.0000000000001040.

    PMID: 27749447
  8. 8

    Pathogenesis of microbial keratitis.

    Lakhundi S, Siddiqui R, Khan NA

    Microbial pathogenesis 2017; (104()):97-109 doi:10.1016/j.micpath.2016.12.013.

    PMID: 27998732
  9. 9

    Comparison of Noncontact Specular and Confocal Microscopy for Evaluation of Corneal Endothelium.

    Huang J, Maram J, Tepelus TC, et al.

    Eye & contact lens 2018; (44 Suppl 1()):S144-S150 doi:10.1097/ICL.0000000000000362.

    PMID: 28346276
  10. 10

    Two-Year Clinical Outcome of 500 Consecutive Cases Undergoing Descemet Membrane Endothelial Keratoplasty.

    Peraza-Nieves J, Baydoun L, Dapena I, et al.

    Cornea 2017; (36(6)):655-660 doi:10.1097/ICO.0000000000001176.

    PMID: 28410548
  11. 11

    Clinical Outcome of Rebubbling for Graft Detachment After Descemet Membrane Endothelial Keratoplasty.

    Gerber-Hollbach N, Baydoun L, López EF, et al.

    Cornea 2017; (36(7)):771-776 doi:10.1097/ICO.0000000000001220.

    PMID: 28437276
  12. 12

    Descemetorhexis Without Grafting for Fuchs Endothelial Dystrophy-Supplementation With Topical Ripasudil.

    Moloney G, Petsoglou C, Ball M, et al.

    Cornea 2017; (36(6)):642-648 doi:10.1097/ICO.0000000000001209.

    PMID: 28476048
  13. 13

    EK (DLEK, DSEK, DMEK): New Frontier in Cornea Surgery.

    Price MO, Gupta P, Lass J, Price FW

    Annual review of vision science 2017; (3()):69-90 doi:10.1146/annurev-vision-102016-061400.

    PMID: 28697678
  14. 14

    Peripheral Endothelial Cell Count Is a Predictor of Disease Severity in Advanced Fuchs Endothelial Corneal Dystrophy.

    Syed ZA, Tran JA, Jurkunas UV

    Cornea 2017; (36(10)):1166-1171 doi:10.1097/ICO.0000000000001292.

    PMID: 28731879
  15. 15

    [Clinical and functional results of one-step phaco surgery and central descemetorhexis for cataract and Fuchs primary endothelial corneal dystrophy].

    Malyugin BE, Izmaylova SB, Malyutina EA, et al.

    Vestnik oftalmologii 2017; (133(6)):16-22 doi:10.17116/oftalma2017133616-22.

    PMID: 29319665
  16. 16

    Corneal Optical Changes Associated with Induced Edema in Fuchs Endothelial Corneal Dystrophy.

    Wacker K, McLaren JW, Kane KM, Patel SV

    Cornea 2018; (37(3)):313-317 doi:10.1097/ICO.0000000000001465.

    PMID: 29408827
  17. 17

    DMEK versus DSAEK for Fuchs' endothelial dystrophy: A meta-analysis.

    Marques RE, Guerra PS, Sousa DC, et al.

    European journal of ophthalmology 2019; (29(1)):15-22 doi:10.1177/1120672118757431.

    PMID: 29661044
  18. 18

    Repeatability and Intersession Reproducibility of Pentacam Corneal Thickness Maps in Fuchs Dystrophy and Endothelial Keratoplasty.

    Mingo-Botín D, Arnalich-Montiel F, Couceiro de Juan A, Ortiz-Toquero S

    Cornea 2018; (37(8)):987-992 doi:10.1097/ICO.0000000000001634.

    PMID: 29781926
  19. 19

    Determining Subclinical Edema in Fuchs Endothelial Corneal Dystrophy: Revised Classification using Scheimpflug Tomography for Preoperative Assessment.

    Sun SY, Wacker K, Baratz KH, Patel SV

    Ophthalmology 2019; (126(2)):195-204 doi:10.1016/j.ophtha.2018.07.005.

    PMID: 30153944
  20. 20

    Descemetorhexis Without Endothelial Keratoplasty Versus DMEK for Treatment of Fuchs Endothelial Corneal Dystrophy.

    Huang MJ, Kane S, Dhaliwal DK

    Cornea 2018; (37(12)):1479-1483 doi:10.1097/ICO.0000000000001742.

    PMID: 30222714
  21. 21

    Corneal transplantation for Fuchs´ endothelial dystrophy: A comparison of three surgical techniques concerning 10 year graft survival and visual function.

    van Rooij J, Lucas EH, Geerards AJ, et al.

    PloS one 2018; (13(10)):e0203993 doi:10.1371/journal.pone.0203993.

    PMID: 30289925
  22. 22

    Use of Topical Rho Kinase Inhibitors in the Treatment of Fuchs Dystrophy After Descemet Stripping Only.

    Macsai MS, Shiloach M

    Cornea 2019; (38(5)):529-534 doi:10.1097/ICO.0000000000001883.

    PMID: 30720541
  23. 23

    Histopathology of a retrocorneal membrane after Descemet membrane endothelial keratoplasty: a case report.

    Bayyoud T, Rohrbach JM, Bartz-Schmidt KU, Thaler S

    Journal of medical case reports 2019; (13(1)):31 doi:10.1186/s13256-018-1960-0.

    PMID: 30728083
  24. 24

    Imaging the Corneal Endothelium in Fuchs Corneal Endothelial Dystrophy.

    Ong Tone S, Jurkunas U

    Seminars in ophthalmology 2019; (34(4)):340-346 doi:10.1080/08820538.2019.1632355.

    PMID: 31215821
  25. 25

    Regional variability in corneal endothelial cell density between guttae and non-guttae areas in Fuchs endothelial corneal dystrophy.

    Ong Tone S, Bruha MJ, Böhm M, et al.

    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2019; (54(5)):570-576 doi:10.1016/j.jcjo.2018.12.009.

    PMID: 31564347
  26. 26

    Predicting the Prognosis of Fuchs Endothelial Corneal Dystrophy by Using Scheimpflug Tomography.

    Patel SV, Hodge DO, Treichel EJ, et al.

    Ophthalmology 2020; (127(3)):315-323 doi:10.1016/j.ophtha.2019.09.033.

    PMID: 31685256
  27. 27

    The Rapid Transformation of Transplantation for Corneal Endothelial Diseases: An Evolution From Penetrating to Lamellar to Cellular Transplants.

    Zhang J, Patel DV, McGhee CNJ

    Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2019; (8(6)):441-447 doi:10.1097/APO.0000000000000265.

    PMID: 31789646
  28. 28

    Morning Myopic Shift and Glare in Advanced Fuchs Endothelial Corneal Dystrophy.

    Loreck N, Adler W, Siebelmann S, et al.

    American journal of ophthalmology 2020; (213()):69-75 doi:10.1016/j.ajo.2020.01.011.

    PMID: 31954712
  29. 29

    Microscope Integrated Intraoperative Optical Coherence Tomography-Guided DMEK in Corneas with Poor Visualization.

    Sharma N, Sahay P, Maharana PK, et al.

    Clinical ophthalmology (Auckland, N.Z.) 2020; (14()):643-651 doi:10.2147/OPTH.S230195.

    PMID: 32184553
  30. 30

    Descemet Membrane Endothelial Keratoplasty versus Ultrathin Descemet Stripping Automated Endothelial Keratoplasty: A Multicenter Randomized Controlled Clinical Trial.

    Dunker SL, Dickman MM, Wisse RPL, et al.

    Ophthalmology 2020; (127(9)):1152-1159 doi:10.1016/j.ophtha.2020.02.029.

    PMID: 32386811
  31. 31

    Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis.

    Ong Tone S, Kocaba V, Böhm M, et al.

    Progress in retinal and eye research 2021; (80()):100863 doi:10.1016/j.preteyeres.2020.100863.

    PMID: 32438095
  32. 32

    Descemet Stripping Only Supplemented With Topical Ripasudil for Fuchs Endothelial Dystrophy 12-Month Outcomes of the Sydney Eye Hospital Study.

    Moloney G, Garcerant Congote D, Hirnschall N, et al.

    Cornea 2021; (40(3)):320-326 doi:10.1097/ICO.0000000000002437.

    PMID: 32740006
  33. 33

    Molecular Mechanisms of Fuchs and Congenital Hereditary Endothelial Corneal Dystrophies.

    Malhotra D, Casey JR

    Reviews of physiology, biochemistry and pharmacology 2020; (178()):41-81 doi:10.1007/112_2020_39.

    PMID: 32789790
  34. 34

    Update on the Surgical Management of Fuchs Endothelial Corneal Dystrophy.

    Blitzer AL, Colby KA

    Ophthalmology and therapy 2020; (9(4)):757-765 doi:10.1007/s40123-020-00293-3.

    PMID: 32840804
  35. 35

    New severity grading system for Fuchs endothelial corneal dystrophy using anterior segment optical coherence tomography.

    Yasukura Y, Oie Y, Kawasaki R, et al.

    Acta ophthalmologica 2021; (99(6)):e914-e921 doi:10.1111/aos.14690.

    PMID: 33258212
  36. 36

    Disease Expression and Familial Transmission of Fuchs Endothelial Corneal Dystrophy With and Without CTG18.1 Expansion.

    Xu TT, Li YJ, Afshari NA, et al.

    Investigative ophthalmology & visual science 2021; (62(1)):17 doi:10.1167/iovs.62.1.17.

    PMID: 33444430
  37. 37

    Diseases of the corneal endothelium.

    Jeang LJ, Margo CE, Espana EM

    Experimental eye research 2021; (205()):108495 doi:10.1016/j.exer.2021.108495.

    PMID: 33596440
  38. 38

    Descemet Membrane Endothelial Keratoplasty versus Descemet Stripping Automated Endothelial Keratoplasty in Complicated Vitrectomized Eyes.

    Mimouni M, Sorkin N, Slomovic J, et al.

    Current eye research 2021; (46(9)):1283-1290 doi:10.1080/02713683.2021.1892150.

    PMID: 33657945
  39. 39

    Pilot Study of Corneal Clearance With the Use of a Rho-Kinase Inhibitor After Descemetorhexis Without Endothelial Keratoplasty for Fuchs Endothelial Corneal Dystrophy.

    Davies E, Jurkunas U, Pineda R

    Cornea 2021; (40(7)):899-902 doi:10.1097/ICO.0000000000002691.

    PMID: 33758139
  40. 40

    Hyperosmolar Eye Drops for Diurnal Corneal Edema in Fuchs' Endothelial Dystrophy: A Double-Masked, Randomized Controlled Trial.

    Zander DB, Böhringer D, Fritz M, et al.

    Ophthalmology 2021; (128(11)):1527-1533 doi:10.1016/j.ophtha.2021.04.015.

    PMID: 33892048
  41. 41

    The "Two-Flaps" Technique for Descemet Stripping Only.

    Cohen E, Din N, Mimouni M, et al.

    Cornea 2021; (40(9)):1211-1214 doi:10.1097/ICO.0000000000002744.

    PMID: 34029237
  42. 42

    Genetic mutations and molecular mechanisms of Fuchs endothelial corneal dystrophy.

    Liu X, Zheng T, Zhao C, et al.

    Eye and vision (London, England) 2021; (8(1)):24 doi:10.1186/s40662-021-00246-2.

    PMID: 34130750
  43. 43

    Long-term Outcomes in Fellow Eyes Comparing DSAEK and DMEK for Treatment of Fuchs Corneal Dystrophy.

    Weisenthal RW, Yin HY, Jarstad AR, et al.

    American journal of ophthalmology 2022; (233()):216-226 doi:10.1016/j.ajo.2021.06.013.

    PMID: 34157279
  44. 44

    Challenges in the complex management of post-keratoplasty glaucoma.

    Anders LM, Gatzioufas Z, Grieshaber MC

    Therapeutic advances in ophthalmology 2021; (13()):25158414211031397 doi:10.1177/25158414211031397.

    PMID: 34350382
  45. 45

    Is there a genetic link between Keratoconus and Fuch's endothelial corneal dystrophy?

    Gurnani B, Kaur K, Tripathy K

    Medical hypotheses 2021; (157()):110699 doi:10.1016/j.mehy.2021.110699.

    PMID: 34666260
  46. 46

    Cataract surgery and intraocular lens placement in patients with Fuchs corneal dystrophy: a review of the current literature.

    Moshirfar M, Huynh R, Ellis JH

    Current opinion in ophthalmology 2022; (33(1)):21-27 doi:10.1097/ICU.0000000000000816.

    PMID: 34743088
  47. 47

    Demographic profile and clinical course of Fuchs endothelial corneal dystrophy in Mexican patients.

    Barrera-Sanchez M, Hernandez-Camarena JC, Ruiz-Lozano RE, et al.

    International ophthalmology 2022; (42(4)):1299-1309 doi:10.1007/s10792-021-02117-0.

    PMID: 34743257
  48. 48

    Therapeutic contact lens for Fuchs endothelial corneal dystrophy: Monitoring with Scheimpflug tomography.

    Erdinest N, London N, Levinger N, Lavy I

    American journal of ophthalmology case reports 2022; (25()):101242 doi:10.1016/j.ajoc.2021.101242.

    PMID: 34950806
  49. 49

    Reticular epithelial corneal edema as a novel side-effect of Rho Kinase Inhibitors: An Indian scenario.

    Bhargava M, Sen S, Bhambhani V, et al.

    Indian journal of ophthalmology 2022; (70(4)):1163-1170 doi:10.4103/ijo.IJO_2865_21.

    PMID: 35326007
  50. 50

    Surgical Management of Fuchs Endothelial Corneal Dystrophy: A Treatment Algorithm and Individual Patient Meta-Analysis of Descemet Stripping Only.

    Din N, Cohen E, Popovic M, et al.

    Cornea 2022; (41(9)):1188-1195 doi:10.1097/ICO.0000000000002975.

    PMID: 35942547
  51. 51

    Fuchs endothelial corneal dystrophy: current perspectives on diagnostic pathology and genetics-Bowman Club Lecture.

    Thaung C, Davidson AE

    BMJ open ophthalmology 2022; (7(1)) doi:10.1136/bmjophth-2022-001103.

    PMID: 36161831
  52. 52

    The soil and the seed: The relationship between Descemet's membrane and the corneal endothelium.

    Petrela RB, Patel SP

    Experimental eye research 2023; (227()):109376 doi:10.1016/j.exer.2022.109376.

    PMID: 36592681
  53. 53

    Recurrence of Guttae and Endothelial Dysfunction After Successful Descemet Stripping Only in Fuchs Dystrophy.

    Kaufman AR, Bal S, Boakye J, Jurkunas UV

    Cornea 2023; (42(8)):1037-1040 doi:10.1097/ICO.0000000000003221.

    PMID: 36729028
  54. 54

    Descemet Stripping Without Endothelial Keratoplasty in Early-Stage Central Fuchs Endothelial Dystrophy: Long-term Results.

    Vieira R, Castro C, Coelho J, et al.

    Cornea 2023; (42(8)):980-985 doi:10.1097/ICO.0000000000003131.

    PMID: 36731082
  55. 55

    Long-Term Outcomes of Descemet Membrane Endothelial Keratoplasty: Effect of Surgical Indication and Disease Severity.

    Vasiliauskaite I, Kocaba V, van Dijk K, et al.

    Cornea 2023; (42(10)):1229-1239 doi:10.1097/ICO.0000000000003130.

    PMID: 36731083
  56. 56

    Risk Factors for Descemet Membrane Endothelial Keratoplasty Rejection: Current Perspectives- Systematic Review.

    Gurnani B, Kaur K, Lalgudi VG, Tripathy K

    Clinical ophthalmology (Auckland, N.Z.) 2023; (17()):421-440 doi:10.2147/OPTH.S398418.

    PMID: 36755886
  57. 57

    Ten-Year Changes in Vision, Refractive Error, and Corneal Thickness After Descemet Stripping Automated Endothelial Keratoplasty for Fuchs Endothelial Corneal Dystrophy.

    Patel SV, Hodge DO, Nau CB

    Cornea 2024; (43(2)):233-236 doi:10.1097/ICO.0000000000003289.

    PMID: 37018761
  58. 58

    Comparison of Long-Term Outcomes of DSEK and DMEK in Fuchs Endothelial Dystrophy.

    Fu L, Hollick EJ

    Cornea 2024; (43(2)):184-189 doi:10.1097/ICO.0000000000003310.

    PMID: 37170402
  59. 59

    Association Between Fuchs Endothelial Corneal Dystrophy, Diabetes Mellitus, and Multimorbidity.

    Nealon CL, Halladay CW, Gorman BR, et al.

    Cornea 2023; (42(9)):1140-1149 doi:10.1097/ICO.0000000000003311.

    PMID: 37170406
  60. 60

    Multi-ancestry GWAS of Fuchs corneal dystrophy highlights roles of laminins, collagen, and endothelial cell regulation.

    Peachey N, Gorman B, Francis M, et al.

    Research square 2023; doi:10.21203/rs.3.rs-2762003/v1.

    PMID: 37205546
  61. 61

    Role of descemet's stripping without keratoplasty in management of endothelial disease.

    Northey LC, Moloney G

    Current opinion in ophthalmology 2023; (34(4)):348-353 doi:10.1097/ICU.0000000000000963.

    PMID: 37254864
  62. 62

    Influence of Subclinical Corneal Edema on Contrast Sensitivity in Fuchs Endothelial Corneal Dystrophy.

    Friedrich M, Hofmann CA, Chychko L, et al.

    Cornea 2024; (43(9)):1154-1161 doi:10.1097/ICO.0000000000003414.

    PMID: 37889563
  63. 63

    Prevalence and Economic Burden of Fuchs Endothelial Corneal Dystrophy in the Medicare Population in the United States.

    Singh RB, Parmar UPS, Kahale F, et al.

    Cornea 2024; (43(8)):1022-1027 doi:10.1097/ICO.0000000000003416.

    PMID: 37906001
  64. 64

    Descemet membrane endothelial keratoplasty compared with ultrathin Descemet stripping automated endothelial keratoplasty: a meta-analysis.

    Sela TC, Iflah M, Muhsen K, Zahavi A

    BMJ open ophthalmology 2023; (8(1)) doi:10.1136/bmjophth-2023-001397.

    PMID: 37914389
  65. 65

    Descemet Stripping Only: Long-Term Outcomes.

    Hakim FE, Nagra AK, Dhaliwal DK

    Cornea 2024; (43(8)):994-998 doi:10.1097/ICO.0000000000003421.

    PMID: 37921677
  66. 66

    Assessing Fuchs Corneal Endothelial Dystrophy Using Artificial Intelligence-Derived Morphometric Parameters From Specular Microscopy Images.

    Prada AM, Quintero F, Mendoza K, et al.

    Cornea 2024; (43(9)):1080-1087 doi:10.1097/ICO.0000000000003460.

    PMID: 38334475
  67. 67

    Predicting Long-Term Endothelial Cell Loss after Preloaded Descemet Membrane Endothelial Keratoplasty in Fuchs' Endothelial Corneal Dystrophy: A Mathematical Model.

    Viola P, Neri E, Occhipinti T, et al.

    Journal of clinical medicine 2024; (13(3)) doi:10.3390/jcm13030877.

    PMID: 38337570
  68. 68

    Fuchs endothelial corneal dystrophy: an updated review.

    Altamirano F, Ortiz-Morales G, O'Connor-Cordova MA, et al.

    International ophthalmology 2024; (44(1)):61 doi:10.1007/s10792-024-02994-1.

    PMID: 38345780
  69. 69

    In vivo confocal microscopy findings after Descemet stripping only with and without topical ripasudil supplementation in Fuchs endothelial dystrophy.

    Northey LC, Oliver C, Trinh T, et al.

    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2024; (59(6)):e682-e690 doi:10.1016/j.jcjo.2024.02.016.

    PMID: 38503406
  70. 70

    Therapeutic future of Fuchs endothelial corneal dystrophy: An ongoing way to explore.

    Liu JX, Chiang TL, Hung KF, Sun YC

    Taiwan journal of ophthalmology 2024; (14(1)):15-26 doi:10.4103/tjo.TJO-D-23-00115.

    PMID: 38654984
  71. 71

    [Modern techniques and features of selective keratoplasty].

    Yusef YN, Osipyan GA, Fisenko NV, Dzamikhova AK

    Vestnik oftalmologii 2024; (140(2. Vyp. 2)):150-157 doi:10.17116/oftalma2024140022150.

    PMID: 38739145
  72. 72

    Diurnal changes of corneal epithelial and stromal thickness maps and visual quality in mild form of Fuchs' endothelial corneal dystrophy.

    Krolo I, Bećirević AK, Radman I, et al.

    Indian journal of ophthalmology 2025; (73(1)):122-127 doi:10.4103/IJO.IJO_282_24.

    PMID: 39257077
  73. 73

    Ten-year outcomes after DMEK, DSAEK, and PK: insights on graft survival, endothelial cell density loss, rejection and visual acuity.

    Wilhelm TI, Gauché L, Böhringer D, et al.

    Scientific reports 2025; (15(1)):1249 doi:10.1038/s41598-025-85138-4.

    PMID: 39774993
  74. 74

    Genetic and Demographic Determinants of Fuchs Endothelial Corneal Dystrophy Risk and Severity.

    Liu S, Sadan AN, Bhattacharyya N, et al.

    JAMA ophthalmology 2025; (143(4)):338-347 doi:10.1001/jamaophthalmol.2025.0109.

    PMID: 40079965
  75. 75

    Review of the Literature: Surgery Indications for Fuchs' Endothelial Corneal Dystrophy.

    Tourabaly M, Knoeri J, Georgeon C, Borderie V

    Journal of clinical medicine 2025; (14(7)) doi:10.3390/jcm14072365.

    PMID: 40217815
  76. 76

    Fellow Eye Comparison of Tomographic Parameters and Higher-Order Aberrations in Ultrathin Descemet Stripping Automated Endothelial Keratoplasty and Descemet Membrane Endothelial Keratoplasty.

    Berger T, Seitz B, Suffo S, et al.

    Klinische Monatsblatter fur Augenheilkunde 2026; (243(2)):139-145 doi:10.1055/a-2558-2583.

    PMID: 40267949
  77. 77

    One year follow up of descemet stripping only: corneal tomography changes and visual acuity outcomes.

    Cuadrado AV, Sánchez-Ventosa Á, González-Cruces T, et al.

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2025; (263(9)):2593-2608 doi:10.1007/s00417-025-06747-3.

    PMID: 40325211
  78. 78

    Delphi-Based Global Consensus on Fuchs Endothelial Corneal Dystrophy. An Endothelial Keratoplasty Learners Group Initiative.

    Patel SV, Gupta N, Bhogal M, et al.

    American journal of ophthalmology 2025; (280()):130-143 doi:10.1016/j.ajo.2025.08.012.

    PMID: 40789362
  79. 79

    10-Year outcome of descemet stripping only in a patient with Fuchs endothelial dystrophy: a case report.

    Moayed F, Steindor FA, Armeni ZE, et al.

    Therapeutic advances in ophthalmology 2025; (17()):25158414251359583 doi:10.1177/25158414251359583.

    PMID: 40893444
  80. 80

    Microbial keratitis in the age of resistance: unlocking the therapeutic potential of phage therapy.

    Ibrahim R, Kumar P, Aranjani JM

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2025; (263(12)):3287-3299 doi:10.1007/s00417-025-06961-z.

    PMID: 40965568
  81. 81

    Sterile Corneal Infiltrate: A Difficult Dilemma.

    Cheraqpour K

    Ocular immunology and inflammation 2025; (33(10)):2510-2517 doi:10.1080/09273948.2025.2580346.

    PMID: 41137571
  82. 82

    Diurnal Variation in Corneal Stromal and Epithelial Thickness in Fuchs Endothelial Corneal Dystrophy: With and Without Intensified Hypertonic Saline Eyedrop Application.

    Cieplucha M, Menzel-Severing J, Steindor F, et al.

    Cornea 2026; (45(11)):1385-1391 doi:10.1097/ICO.0000000000004041.

    PMID: 41199516
  83. 83

    Corneal transplantation triple procedures.

    Nair S, Deshmukh R, Mohan S, et al.

    Survey of ophthalmology 2026; (71(3)):909-924 doi:10.1016/j.survophthal.2025.12.006.

    PMID: 41485730
  84. 84

    Beyond keratoplasty: The role of Descemet stripping only in the management of Fuchs endothelial dystrophy-a systematic review and meta-analysis.

    Sahin Vural G, Akgun Z, Barut Selver O

    Survey of ophthalmology 2026; (71(5)):1468-1477 doi:10.1016/j.survophthal.2026.03.010.

    PMID: 41856174
  85. 85

    Injectable corneal endothelial cell therapy: recent progress, translational barriers, and future directions.

    Mohammed G, Tayyab MA, Hussain J, et al.

    Frontiers in ophthalmology 2026; (6()):1799892 doi:10.3389/fopht.2026.1799892.

    PMID: 42183087
  86. 86

    Descemet Stripping Only in Fuchs Endothelial Corneal Dystrophy: Results of a Randomized Clinical Trial of Topical Ripasudil and Directions for Future Innovation.

    Colby K, Kruse FE, Kinoshita S

    American journal of ophthalmology 2026; (290()):145-160 doi:10.1016/j.ajo.2026.06.014.

    PMID: 42303065
  87. 87

    Soft-shell phacoemulsification in Fuchs' endothelial dystrophy: Central corneal thickness as a predictor of post-operative keratoplasty.

    Teh BL, Tzoumas N, Boso ALM, et al.

    European journal of ophthalmology 2026; 11206721261445518 doi:10.1177/11206721261445518.

    PMID: 42312880
  88. 88

    Association between subjective symptoms and severity in patients with Fuchs endothelial corneal dystrophy.

    Koizumi Y, Oie Y, Maeno S, et al.

    Japanese journal of ophthalmology 2026; (70(5)):1066-1072 doi:10.1007/s10384-026-01391-8.

    PMID: 42397667
  89. 89

    Genome-Wide Association Study of Corneal Dystrophy Uncovers Novel Risk Loci and Enables Improved Polygenic Prediction of Fuchs Endothelial Corneal Dystrophy.

    Insawang B, Mackey DA, Hewitt AW, et al.

    Investigative ophthalmology & visual science 2026; (67(10)):40 doi:10.1167/iovs.67.10.40.

    PMID: 42606190
  90. 90

    Comparative Outcomes From 969 Endothelial Keratoplasties.

    Di Zazzo A, Laborante M, De Luca A, et al.

    Cornea 2026; doi:10.1097/ICO.0000000000004276.

    PMID: 42635036
  91. 91

    The impact of overlooked Fuchs' Endothelial Corneal Dystrophy: postoperative results following intraocular interventions.

    Sahin Vural G, Avci F

    International ophthalmology 2026; (46(1)).

    PMID: 42782391
  92. 92

    Structural correlates of multidimensional visual dysfunction in Fuchs endothelial corneal dystrophy.

    Akagi A, Inoue T, Kiruba R, et al.

    Japanese journal of ophthalmology 2026; doi:10.1007/s10384-026-01435-z.

    PMID: 42828609